Lack of P2Y13 in mice fed a high cholesterol diet results in decreased hepatic cholesterol content, biliary lipid secretion and reverse cholesterol transport

Nutrition and Metabolism

Volumn 10, Issue 1, 2013, Pages

  Lichtenstein, Laeticia ^a,b   Serhan, Nizar ^a,b   Annema, Wijtske ^c   Combes, Guillaume ^a,b   Robaye, Bernard ^d   Boeynaems, Jean Marie ^d   Perret, Bertrand ^a,e   Tietge, Uwe J F ^c   Laffargue, Muriel ^a,b   Martinez, Laurent O ^a,b,e  

^a University Hospital of Toulouse   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^e CHU PURPAN   (France)

Author keywords

ATP synthase; Bile lipid secretions; Cholesterol metabolism; HDL; HDL uptake; High cholesterol diet; Liver; P2Y13; Reverse cholesterol transport

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; PHOSPHOLIPID; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PURINERGIC P2Y13 RECEPTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BILE SECRETION; CHOLESTEROL BILE LEVEL; CHOLESTEROL DIET; CHOLESTEROL INTAKE; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; COMMON BILE DUCT; CONTROLLED STUDY; DYSLIPIDEMIA; ENDOCYTOSIS; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KNOCKOUT GENE; LIPID ANALYSIS; LIPID BILE LEVEL; LIPID BLOOD LEVEL; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PHOSPHOLIPID BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA; MUS;

EID: 84887053088     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-10-67     Document Type: Article

References (16)

1. Cardiovascular disease and dyslipidemia: beyond LDL. Pöss J, Custodis F, Werner C, Weingärtner O, Böhm MLU, Curr Pharm Des 2011 17 861 870 10.2174/138161211795428858 21418031
2. Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. DeGoma EM, DeGoma RL, Rader DJ, J Am Coll Cardiol 2008 51 2199 2211 10.1016/j.jacc.2008.03.016 18534265 (Pubitemid 351754991)
3. Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabezon E, Champagne E, et al. Nature 2003 421 75 79 10.1038/nature01250 12511957 (Pubitemid 36077087)
4. P2Y13 receptor is critical for reverse cholesterol transport. Fabre AC, Malaval C, Ben Addi A, Verdier C, Pons V, Serhan N, et al. Hepatology 2010 52 1477 1483 10.1002/hep.23897 20830789
5. Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion. Serhan N, Cabou C, Verdier C, Lichtenstein L, Malet N, Perret B, et al. Biochim Biophys Acta 2013 1831 719 725 10.1016/j.bbalip.2012.12.006 23266391
6. Pancreatic β-cell function relates positively to HDL functionality in well-controlled type 2 diabetes mellitus. Dullaart RPF, Annema W, de Boer JF, Tietge UJF, Atherosclerosis 2012 222 567 573 10.1016/j.atherosclerosis.2012.03. 037 22541874
7. Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice. Nijstad N, de Boer JF, Lagor WR, Toelle M, Usher D, Annema W, et al. Biochim Biophys Acta 2011 1811 294 299 10.1016/j.bbalip.2011.01.008 21296681
8. Quantitative assessment of atherosclerotic lesions in mice. Paigen B, Morrow A, Holmes PA, Mitchell DWR, Atherosclerosis 1987 68 231 240 10.1016/0021-9150(87)90202-4 3426656 (Pubitemid 17159775)
9. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice. Nijstad N, Gautier T, Briand F, Rader DJ, Tietge UJF, Gastroenterology 2011 140 1043 1051 10.1053/j.gastro.2010.11.055 21134376
10. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Naik SU, Wang X, Da Silva JS, Jaye M, Macphee CH, Reilly MP, et al. Circulation 2006 113 90 97 16365197 (Pubitemid 43958493)
11. The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis. Jacquet S, Malaval C, Martinez LO, Sak K, Rolland C, Perez C, et al. Cell Mol Life Sci 2005 62 2508 2515 10.1007/s00018-005-5194- 0 16231090 (Pubitemid 41801103)
12. Both the Peroxisome Proliferator-Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL-Derived Cholesterol. François B, Snehal U, Naik Llia F, John S, Millar C, Colin M, Max W, Jeffrey B, George Rothblat DJ, Clin Transl Sci 2009 2 127 133 10.1111/j.1752-8062.2009.00098.x 20169010
13. Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice. Dikkers A, Freak De Boer J, Annema W, Groen AK, Tietge UJF, Hepatology 2013 58 293 303 10.1002/hep.26316 23401258
14. Europe PMC Funders Group Characterization of endocytic compartments after holo-high density lipoprotein particle uptake in HepG2 cells. Röhrl C, Pagler TA, Ellinger A, Pavelka M, Meisslitzer-ruppitsch C, Histochem Cell Biol 2011 133 261 272
15. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. Haghpassand M, Bourassa PK, Francone OL, Aiello RJ, J Clin Invest 2001 108 1315 1320 11696576 (Pubitemid 33107759)
16. Identification of a novel human ADP receptor coupled to G(i). Communi D, Gonzalez NS, Detheux M, Brezillon S, Lannoy V, Parmentier M, et al. J Biol Chem 2001 276 41479 41485 10.1074/jbc.M105912200 11546776